FindTrial
Sign In

Construction and validation of a bleeding and ischemia risk model in elderly patients with acute coronary syndrome and atrial fibrillation

Clinical application of PARIS score in guiding antithrombotic therapy strategies in elderly patients with acute coronary syndrome and atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067185
Enrollment
Unknown
Registered
2022-12-29
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome and atrial fibrillation

Interventions

Case series:none

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ? Aged = 75 years old, male or female elderly patients with ACS complicated with atrial fibrillation ? Past history of paroxysmal atrial fibrillation, or electrocardiogram confirmed that the new-onset atrial fibrillation has been converted to drug or non-drug therapy

Exclusion criteria

Exclusion criteria: ? Atrial fibrillation caused by valve disease ? Women who are pregnant or planning to become pregnant ? Severe heart failure, NYHA class IV cardiac function ?Severe renal insufficiency (eGFR3ULN) ?Allergy history ?Electrolyte disturbance ?Malignant tumor

Design outcomes

Secondary

MeasureTime frame
Major Adverse Cardiovascular Events;—

Primary

MeasureTime frame
hemorrhagic or ischemic event;—

Countries

China

Contacts

Public ContactLiu Yuqi

Chinese PLA General Hospital

ametuofo980869@163.com010-55499309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026